Cover Image
QR Code

Bioequivalence and Safety Study of Ranolazine Extended-Release Tablets in Chinese Healthy Subjects Under Fasting and Fed Conditions: A Randomized, Open-Label, Single-Dose, Cross-Over, Comparative Pharmacokinetic Study.

Published in:Clinical Therapeutics Vol. 48; no. 1; pp. 88 - 95
Main Authors: Chen, Xing, Li, Yaming, Ma, Genshan
Format: Journal Article
Published: Elsevier B.V. Jan2026
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=190937777&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 190937777
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01492918
        H3L
      jtl: Clinical Therapeutics
      issn: 01492918
      maglogo: N
    pubinfo:
      dt: Jan2026
      vid: 48
      iid: 1
      pid: 82545
      pub: Elsevier B.V.
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        190937777
        10.1016/j.clinthera.2025.11.002
        190937777
      ppf: 88
      ppct: 7
      formats:
      tig:
        atl: Bioequivalence and Safety Study of Ranolazine Extended-Release Tablets in Chinese Healthy Subjects Under Fasting and Fed Conditions: A Randomized, Open-Label, Single-Dose, Cross-Over, Comparative Pharmacokinetic Study.
      aug:
        au:
          Chen, Xing
          Li, Yaming
          Ma, Genshan
        affil: Pharmaceutical Department, Jiangsu Province (Suqian) Hospital, Suqian, Jiangsu, China
      sug:
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N